Clik here to view.
Improving Canadian Rare Disease Patients’ Access to Treatment
Sean McBrideNational Director of Specialty Commercial Operations, Bayshore Specialty Rx Bayshore Specialty Rx is on a mission to help rare disease patients across Canada gain access to the treatments...
View ArticlePutting people at the core of cancer research to drive life-changing progress
Over the last 30 years, thanks in large part to research, tremendous progress has been made against many cancers. Today, 64 per cent of people diagnosed with cancer in Canada are expected to survive...
View ArticleHow McMaster Innovation Park Is Advancing Cell and Gene Therapy
McMaster Innovation Park is fostering an innovation ecosystem for life sciences and biotech researchers, entrepreneurs, and ventures. The cell and gene therapy (CGT) sector in Ontario is rapidly...
View ArticleClik here to view.
How Ontario Is Leading the Way in the Medical Isotopes Field
Jason Van WartPresident, Laurentis Energy Partners Ontario-based Laurentis Energy Partners is an innovative leader and producer of medical isotopes, which are transforming global health care. What do...
View ArticleClik here to view.
Celebrating 10 Years of AbbVie Leadership
Tracey RamsayVice-President and General Manager of AbbVie Canada AbbVie celebrating 10 years of making a remarkable impact. AbbVie’s 10th anniversary marks an important milestone. In Canada, over the...
View ArticleClik here to view.
Amylyx Pharmaceuticals Puts Canadians Living with ALS First
Josh Cohen Co-Founder & Co-CEO, Amylyx Pharmaceuticals Justin Klee Co-Founder & Co-CEO, Amylyx Pharmaceuticals Chris Aiello General Manager & Head of Canada, Amylyx Pharmaceuticals...
View ArticleClik here to view.
Novartis Invests in the Montréal Health Innovation District to Foster a New...
Andrea MarazziCountry President, Novartis Pharmaceuticals Canada The launch of Novartis’ new Montréal head office heralds a renewed commitment to collaboration and innovation within Canada. Novartis...
View ArticleAccess to Immunotherapy for Hard-to-Treat Lymphoma Improving
Now widely available across Canada as a third-line treatment for B-cell lymphomas, CAR T focus now on second-line treatment. Researchers in cancer medicine have been studying immunotherapies for...
View ArticleCell and Gene Therapy — Canada’s Chance To Be a Global Leader in Life Sciences
Canada is well on the way to becoming a global leader in the commercialization, investment, and manufacturing of cell and gene therapies. Canada’s scientific community has a rich legacy of success....
View ArticleWhy Advancing IDEA Is Good for Canada’s Life Sciences Sector
To enhance Canada’s life sciences sector, embedding inclusion, diversity, equity, and accessibility (IDEA) is crucial for fostering innovation and attracting talent. Canada currently ranks among the...
View Article
